Showing results (331-340 of 347) with videos related to
Sort By:
Pageof 35
The Journal of Clinical Investigation|December 1, 2025
LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9+ macrophages and enhances radiation-induced antitumor immunityJun-Yan Li, Ying-Qing Li, Jia-Hao Dai, et al.Molecular Cancer|February 3, 2026
Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinomaJing-Yun Wang, Ying-Qi Lu, Xi-Rong Tan, et al.Medcomm|April 3, 2026
Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal CarcinomaJun-Yan Li, Yao Yao, Xi-Rong Tan, et al.Journal of Pain and Symptom Management|November 13, 2025
Physicians' Perspectives and Attitudes Toward Palliative Care for Cancer Children in Mainland ChinaAnan Zhang, Xuan Zhou, Jianmin Wang, et al.Cancer Research Communications|August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder CancerMatthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.Journal for Immunotherapy of Cancer|March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.Nature Communications|November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinomaMatthew T Campbell, Surena F Matin, Alda L Tam, et al.Science Translational Medicine|April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapyPavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.Nature Communications|January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trialPavlos Msaouel, Kai Yu, Ying Yuan, et al.Plos Genetics|October 23, 2023
A protease and a lipoprotein jointly modulate the conserved ExoR-ExoS-ChvI signaling pathway critical in Sinorhizobium meliloti for symbiosis with legume hostsJulian A Bustamante, Josue S Ceron, Ivan Thomas Gao, et al.Pageof 35